| NCT Number | NCT07314333 |
| Lead Sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Conditions | ADHD |
| Enrollment | 40 participants |
| Start Date | 2026-02-05 |
| Primary Completion | 2026-03-30 (estimated) |
| Study Completion | 2026-04-15 (estimated) |
| Updated on ClinicalTrials.gov | 2026-05-05 |